| 000 | 01462 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515080754.0 | ||
| 264 | 0 | _c20071227 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSato, Takeo | |
| 245 | 0 | 0 |
_aIrinotecan and S-1 neoadjuvant chemoradiation therapy in patients with advanced rectal cancer. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a1391-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aOxonic Acid _xtherapeutic use |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aRectal Neoplasms _xpathology |
| 650 | 0 | 4 |
_aTegafur _xtherapeutic use |
| 700 | 1 | _aKokuba, Yukihito | |
| 700 | 1 | _aKoizumi, Wasaburo | |
| 700 | 1 | _aOzawa, Heita | |
| 700 | 1 | _aNakamura, Takatoshi | |
| 700 | 1 | _aIhara, Atsushi | |
| 700 | 1 | _aOotani, Yoshimasa | |
| 700 | 1 | _aWatanabe, Masahiko | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 54 _gno. 77 _gp. 1391-3 |
|
| 999 |
_c17239167 _d17239167 |
||